QUANTITATIVE OF PLATELETS AGAINST THE BACKGROUND OF ANTI-VIRUS THERAPY IN CHRONIC HEPATITIS WITH HCV ETIOLOGY.

Liver disease leads to impaired blood clotting mainly due to malfunction of platelet adhesion and aggregation. [7]. This dysfunction is related to the activity of specific enzymes and transaminases in the liver [3,6]. An increase in the activity of transaminases is a sign of cytolytic syndrome, in which a decrease in platelet aggregation is observed [1.].